| Job cadre | |||||||
---|---|---|---|---|---|---|---|---|
Doctor | Nurse | Pharm | CHEW | Lab | Total | χ2 | p value | |
Variable | n (%) | n (%) | n (%) | n (%) | n (%) | N | Â | Â |
T.C | ||||||||
 Optimal | 15(36.6) | 69(33.7) | 2(22.3) | 16(53.3) | 10(62.5) | 112(37.2) | 11.235Y | 0.188 |
 Borderline | 15(36.6) | 80(39.0) | 3(33.3) | 4(13.4) | 2(12.5) | 104(34.6) |  |  |
 High risk | 11(26.8) | 56(27.3) | 4(44.4) | 10(33.3) | 4(25.0) | 85(28.2) |  |  |
HDL | ||||||||
 High risk | 1(2.4) | 16(7.8) | 0(0.0) | 2(6.7) | 3(18.8) | 22(7.3) | 4.128Y | 0.845 |
 Beneficial | 2(4.9) | 21(10.2) | 1(11.1) | 2(6.7) | 0(0.0) | 26(8.6) |  |  |
LDL | ||||||||
 Optimal | 30(73.2) | 150(73.2) | 8(88.8) | 21(70.0) | 12(75.0) | 221(73.4) | 3.199Y | 0.999 |
 Borderline | 6(14.6) | 26(12.7) | 1(11.1) | 6(20.0) | 2(12.5) | 41(13.6) |  |  |
 High risk | 5(12.2) | 29(14.2) | 0(0.0) | 3(10.0) | 2(12.5) | 40(13.0) |  |  |
Triglyceride | ||||||||
 Optimal | 38(92.7) | 181(88.3) | 9(100.0) | 26(86.7) | 16(100.0) | 270(89.7) | 1.458Y | 0.993 |
 Borderline | 1(2.4) | 15(7.3) | 0(0.0) | 3(10.0) | 0(0.0) | 19(6.3) |  |  |
 High risk | 2(4.9) | 9(4.4) | 0(0.0) | 1(3.3) | 0(0.0) | 12(4.0) |  |  |
AIP | ||||||||
 Mild risk | 41(100.0) | 187(91.3) | 91(100.0) | 28(93.4) | 16(100.0) | 281(93.4) | 3.160Y | 0.923 |
 Intermediate | 0(0.0) | 13(6.3) | 0(0.0) | 1(3.3) | 0(0.0) | 14(4.7) |  |  |
 High risk | 0(0.0) | 5(2.4) | 0(0.0) | 1(3.3) | 0(0.0) | 6(2.0) |  |  |